BREAKING NEWS	VIDEO INTERVIEWS Wound Management Technologies, Inc. (OTCBB: WNDM) Wound Management Technologies, Inc., through its subsidiary, Wound Care Innovations, LLC, distributes collagen-based wound care products to healthcare providers, such as physicians, clinics, and hospitals in the United States. It holds worldwide license to certain technologies and processes related to a collagen based wound care product formulation under the brand name CellerateRx. The company markets CellerateRx for pressure ulcers, diabetic ulcers, surgical wounds, ulcers due to arterial insufficiency, traumatic wounds, first and second degree burns, and superficial wounds. It offers CellerateRX in gel and power forms. The company, formerly known as MB Software Corporation, was founded in 1982 and is based in Fort Worth, Texas. Contact: Jon Pappie - 760-669-9521 This media may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this media that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions. To submit a company profile, email valerie@nextinvestor.com.